Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Other(2)

Detailed Status

unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

recruiting133%
unknown267%

Recent Activity

1 active trials
Showing 3 of 3
recruitingphase_1

NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer

NCT05213195
unknownnot_applicable

NKG2D CAR-NK & Ovarian Cancer

NCT05776355
unknownnot_applicable

NKG2D CAR-NK & r/rAML

NCT05734898

Clinical Trials (3)

Showing 3 of 3 trials
NCT05213195Phase 1

NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer

Recruiting
NCT05776355Not Applicable

NKG2D CAR-NK & Ovarian Cancer

Unknown
NCT05734898Not Applicable

NKG2D CAR-NK & r/rAML

Unknown

All 3 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
3